Inactive Instrument

Other languages Impax Laboratories Inc Nasdaq

Equities

US45256B1017

Other languages

Unlock all the news: Be the first to know and act before the market!

Amneal Pharmaceuticals to Develop Omalizumab Biosimilar for Allergy Treatments	Jul. 01
Amneal Pharmaceuticals, Inc. Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab Biosimilar	Jul. 01
Kashiv Biosciences Enters into Exclusive Licensing Agreement with Amneal Pharmaceuticals, Inc. for Commercialization of A Proposed Biosimilar to XOLAIR®	Jul. 01
Amneal Pharmaceuticals, Inc. Expands Broad Injectables Portfolio to over 40 Products with the Addition of Six New Therapies	Jun. 05
Amneal Begins Supplying Over-The-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California	May. 22
Drugmaker Amneal agrees to $270 million U.S. opioid settlement	May. 03
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	May. 03
Amneal Pharmaceuticals Q1 Adjusted Earnings, Revenue Climb	May. 03
Amneal Pharmaceuticals, Inc. Affirms Earnings Guidance for Full Year 2024	May. 03
Amneal Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 03
Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise	Apr. 24
Amneal Announces U.S. FDA Approval of Over-The-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose	Apr. 24
Amneal Pharmaceuticals Announces Launch of Pemetrexed Injection, 100mg/10 Mg/10 Mg/50 Mg/Ll	Apr. 17
Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says	Apr. 12
TSX ends flat as gold stocks drop, mood cautious ahead of rate decision	Apr. 08
Amneal Pharmaceuticals Receives FDA Approval for Ear Infection Treatment	Mar. 25
Amneal Pharmaceuticals, Inc Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension	Mar. 25
Sector Update: Health Care Stocks Edge Higher Premarket Friday	Mar. 01
Sector Update: Health Care	Mar. 01
Exchange-Traded Funds Higher, Equity Futures Lower Pre-Bell Friday as Traders Turn Cautious After Major US Data Releases	Mar. 01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Impax Laboratories Inc Nasdaq

Equities

US45256B1017

Other languages

Filters